logo

The Future of Fate Therapeutics Inc: Analyzing FATE

In terms of market performance, Fate Therapeutics Inc had a fairly even. The highest value for the stock in the past year was $8.83 on 03/07/24, and the lowest value was recorded at $1.63 on 10/30/23.

52-week price history of FATE Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Fate Therapeutics Inc’s current trading price is -22.20% away from its 52-week high, while its distance from the 52-week low is 321.47%. The stock’s price range during the 52-week period has remained between $1.63 and $8.83. In the Healthcare sector, the company’s shares saw a trading volume of around 1.99 million for the day, which was evidently lower than the average daily volume of 2.93 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Fate Therapeutics Inc (FATE) has experienced a quarterly rise of 105.07% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 681.78M and boasts a workforce of 181 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 4.66, with a change in price of +5.14. Similarly, Fate Therapeutics Inc recorded 2,501,767 in trading volume during the last 100 days, posting a change of +297.11%.

Examining FATE’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for FATE stands at 0.28. Similarly, the long-term debt-to-equity ratio is also 0.26.

FATE Stock Stochastic Average

Fate Therapeutics Inc’s raw stochastic average for the past 50 days is presently 58.56%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 14.41%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 28.80% and 30.62%, respectively.

FATE Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Until today this year the stock’s price performance recorded an increase of 83.69%. However, over the last six months, the performance has been weaker by 225.59%. The price of FATE decreased -1.29% over the last 30 days. And in the last five days, it has fallen by -2.41%.